0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Intranasal Lidocaine for Treatment of Migraine

Amir Tulchinsky, MD
JAMA. 1996;276(19):1554. doi:10.1001/jama.1996.03540190026023.
Text Size: A A A
Published online

To the Editor.  —I am concerned that the study by Dr Maizels et al, which shows efficacy for intranasal lidocaine in the treatment of migraine headaches, is a demonstration of the ability of therapy to show a positive response rate when the treatment and placebo are not equivalent. This is an important issue regarding this double-blind randomized controlled study, because intranasal lidocaine is highly irritative and can easily be distinguished from the relatively benign and comfortable instillation of saline that was used as a control. It is reasonable to expect that the treatment that causes more irritation might cause a higher placebo response rate, as has been demonstrated in several reviews of placebo pharmacology.3,4 Patients tend to perceive larger capsules of placebo as being stronger than smaller ones, 2 placebo capsules as producing stronger effects than just 1,2 and injections as producing larger placebo effects than pills.3,4The literature on

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Figures

Tables

References

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();